Results 1 to 10 of about 8,324 (129)
Seasonality and Delirium Tremens in Hospitalized Patients with Alcohol Dependence Syndrome [PDF]
, 2023 Introduction: Due to the high rate of mortality, recognizing the contributing factors of alcohol-related delirium tremens (DT), which is the most severe form of alcohol withdrawal state (AWS) is pivotal in clinical settings.
Andó Bálint +13 more
core +1 more source
Medical Journal Armed Forces India, 2004 The varied clinical manifestations and management of 14 male patients with delirium tremens (DT) have been studied. Eight patients were initially hospitalised for diseases unrelated to ethanol abuse i.e. 2 each for gun shot wound, myocardial infarction and stroke, and one each for pneumonia and gastroenteritis.
S R, Mehta +4 more
openaire +2 more sources
History of Delirium Tremens in AUD Patients in Treatment: Relationship to AUD Severity and Other Factors [PDF]
, 2022 Delirium tremens (DT) occurs after stopping prolonged, high alcohol intake and may be life-threatening if untreated. We need to know about clinical correlates of DT to provide the best clinical care.
Bolstad, Ingeborg +5 more
core +3 more sources
Mortality and alcohol-related morbidity in patients with delirium tremens, alcohol withdrawal state or alcohol dependence in Norway: A register-based prospective cohort study [PDF]
, 2023 Background and Aims: Little is known about long-term consequences of delirium tremens (DT). This study aimed to compare all-cause and cause-specific mortality and alcohol-related morbidity between patients with: (i) DT, (ii) alcohol withdrawal state ...
Bramness, Jørgen Gustav +3 more
core +2 more sources
The Treatment of Alcohol Withdrawal [PDF]
, 1989 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90352/1/j.1875-9114.1989.tb04119.x ...
Guthrie, Sally K.
core +1 more source
GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. [PDF]
, 2014 The present paper summarizes the preclinical and clinical studies conducted to define the "anti-alcohol" pharmacological profile of the prototypic GABAB receptor agonist, baclofen, and its therapeutic potential for treatment of alcohol use disorder (AUD).
Agabio R, Colombo G
core +2 more sources